Proteolytic activation of alternative CCR1 ligands in inflammation.
about
Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their ReceptorsCathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneysEffect of low-level CO2 on innate inflammatory protein response to organic dust from swine confinement barnsMurine lung eosinophil activation and chemokine production in allergic airway inflammation.CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement.MIP-1δ activates NFATc1 and enhances osteoclastogenesis: involvement of both PLCγ2 and NFκB signaling.A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polypsMast cell secretory granules: armed for battle.Beta-Chemokine CCL15 Affects the Adhesion and Migration of Hematopoietic Progenitor Cells.Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axisSynovial mast cells: role in acute and chronic arthritis.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Low serum levels of myeloid progenitor inhibitory factor-1 predict good response to methotrexate in rheumatoid arthritisThe Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part IAnti-chemokine small molecule drugs: a promising future?In vivo regulation of chemokine activity by post-translational modification.Membrane-type matrix metalloproteinases: key mediators of leukocyte function.Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.Pivotal role for alpha1-antichymotrypsin in skin repair.Human Neutrophils Produce CCL23 in Response to Various TLR-Agonists and TNFα.Pulmonary innate inflammatory responses to agricultural occupational contaminants.Regulation of pancreatic inflammation by connective tissue growth factor (CTGF/CCN2).Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16.Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa.Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis.Systemic Chemokine Levels with "Gut-Specific" Vedolizumab in Patients with Inflammatory Bowel Disease-A Pilot StudyRecognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.Extended cleavage specificity of the mast cell chymase from the crab-eating macaque (Macaca fascicularis): an interesting animal model for the analysis of the function of the human mast cell chymase.The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans.Modulation of the allergic asthma transcriptome following resiquimod treatment.
P2860
Q27326691-BDE08DB6-8E38-4E59-92C6-901D3FA481B8Q28290170-52C6EE40-F7E5-4DC5-B271-1C990D7BF5F9Q29247860-330AE35A-28B3-489E-8BDE-C5AEE1BA6B38Q30433116-5D228F0A-C94D-4417-8007-E8180596525CQ30829535-D70E3F04-3D7D-4B98-9C41-F85A90794F86Q33564854-2278CE3B-D6C3-45DD-BD08-C24C479F2751Q33619976-8806B1F4-4BCA-46A1-A416-9AB58D84BAADQ33898964-3F7AD5F1-499A-4C35-9D35-75C595876141Q34333142-16E0DD20-D3EB-4E82-8018-7A33EA4FC2F3Q34336687-841EB7A7-5E7A-4F19-A16D-F62F20819F19Q34389532-72A105AC-9856-4CB7-83C7-B77CF8EAE18FQ35085607-A3D39222-BB48-4386-BE91-8F83118F6B09Q35182662-D7055A84-9A0E-429D-85EB-8F2C3851BD0BQ35507605-9B25A7A1-565D-4CA2-A745-EF1E92183C98Q35604419-5577E542-0B81-4A89-AC58-73E5884554EEQ35604423-8089DD0F-B576-478A-8341-2C68A8114F87Q36057569-2D17F49F-3E8B-4949-A905-5000B2820F28Q36218356-0C2093DF-1B1E-4A0F-BA1E-34CEE422BA3DQ36621030-17FE2809-C18B-4B14-B975-3C3F3959356FQ36819865-942FD5AD-D575-48A7-A19D-997651CD6B8CQ37432097-05D059CE-29D6-4BAF-807E-EF5670678235Q37456872-EF24F339-BC22-4124-9292-A7D6F4629287Q37557971-F5FDE7B1-76EB-41E3-BCAF-906A311157F0Q37683772-9C8D225F-BEB0-41EB-95F9-A4D0260D28DFQ38102877-E67A3EF1-8931-427C-8F20-C812D06ACB96Q38108503-0FDACAF7-8B00-4C31-9BB5-72618B7E998FQ38306649-E0D0CB07-BC70-4424-8EA9-F275714DEA38Q38672932-CDB48DD8-7D92-41CA-8709-8CFB0B93B348Q38758865-BC5A0B1E-19BE-4A66-8D63-C33D38D8A319Q38975032-001C3A0D-9B33-4310-84C2-DBA5C431E5B0Q39002130-4C4F03AE-885E-4939-965F-691E7620456DQ39432022-B143E972-AFF4-4A52-9EC7-FF8D2D94B6BFQ39709081-BD47110B-C4E3-4C35-94EA-3ABFC437F2BAQ39790103-AD23844F-801F-41E5-A98A-12F21435B15FQ40012047-F6CC2D8A-0EB6-4702-95DD-396F5C52F363Q41574652-002C0E48-24F4-4282-AB32-3245592BAE41Q41863417-2B098A44-6730-4D23-BF89-BBDCD13D1658Q42011723-5B59223D-6F56-4CEA-8242-8E5B082CD8ABQ43092468-A1554DED-C55F-49CA-9901-2567F526E692Q45985404-DEAF185A-DA74-44EC-80D1-98B52EBE6D0D
P2860
Proteolytic activation of alternative CCR1 ligands in inflammation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Proteolytic activation of alternative CCR1 ligands in inflammation.
@en
type
label
Proteolytic activation of alternative CCR1 ligands in inflammation.
@en
prefLabel
Proteolytic activation of alternative CCR1 ligands in inflammation.
@en
P2093
P1476
Proteolytic activation of alternative CCR1 ligands in inflammation.
@en
P2093
Brett Premack
Maureen C Howard
Robert D Berahovich
Thomas J Schall
Zhenhua Miao
P304
P356
10.4049/JIMMUNOL.174.11.7341
P407
P577
2005-06-01T00:00:00Z